Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate Cancer - Concepedia

Concepedia

Publication | Closed Access

Multi-Institutional Randomized Phase II Trial of the Epothilone B Analog Ixabepilone (BMS-247550) With or Without Estramustine Phosphate in Patients With Progressive Castrate Metastatic Prostate Cancer

190

Citations

25

References

2005

Year

Matthew D. Galsky, Eric J. Small, William Oh, Isan Chen, David C. Smith, A. Dimitrios Colevas, Lou Martone, Tracy Curley, A. Delacruz, Howard I. Scher,

Journal of Clinical Oncology

Abstract

Ixabepilone, with or without estramustine phosphate, is well tolerated and has antitumor activity in patients with castrate metastatic prostate cancer.

References

	Year	Citations

Page 1